Bookmark
Forward
BCMA-directed therapy for early relapsed and/or refractory multiple myeloma.
Niels W C J van de Donk, Sonja Zweegman
Nature reviews. Clinical oncology 2024 Oct
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Niels W C J van de Donk, Sonja Zweegman.
BCMA-directed therapy for early relapsed and/or refractory multiple myeloma.
Nature reviews. Clinical oncology.
2024 Oct;21(10):707-708
Mesh Tags
Humans
Multiple Myeloma
B-Cell Maturation Antigen
Neoplasm Recurrence, Local
Drug Resistance, Neoplasm
Substances
B-Cell Maturation Antigen
TNFRSF17 protein, human
PMID: 39030279
View Full Text